Literature DB >> 22939650

Who prescribes buprenorphine for rural patients? The impact of specialty, location and practice type in Washington State.

Erik Kvamme1, Mary Catlin, Caleb Banta-Green, John Roll, Roger Rosenblatt.   

Abstract

We determined the specialty, geographic location, practice type and treatment capacity of waivered clinicians in Washington State. We utilized the April 2011 Drug Enforcement Agency roster of all waivered buprenorphine prescribers and cross-referenced the data with information from the American Medical Association and online resources. Waivered physicians, as compared to Washington State physicians overall, are more likely to be primary care providers, be older, less likely to be younger than 35 years, and more likely to be female. Isolated rural areas have the lowest provider to population ratios. Ten counties lack either a buprenorphine provider or a methadone clinic. In rural areas, waivered physicians work predominately in federally-subsidized safety-net settings, which underscores the need for continued governmental support of primary care and mental health in these settings.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22939650      PMCID: PMC3886338          DOI: 10.1016/j.jsat.2012.07.006

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  11 in total

1.  Expanding treatment capacity for opioid dependence with office-based treatment with buprenorphine: National surveys of physicians.

Authors:  Cynthia L Arfken; Chris-Ellyn Johanson; Salvatore di Menza; Charles Roberts Schuster
Journal:  J Subst Abuse Treat       Date:  2010-07-03

2.  Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.

Authors:  Roger D Weiss; Jennifer Sharpe Potter; David A Fiellin; Marilyn Byrne; Hilary S Connery; William Dickinson; John Gardin; Margaret L Griffin; Marc N Gourevitch; Deborah L Haller; Albert L Hasson; Zhen Huang; Petra Jacobs; Andrzej S Kosinski; Robert Lindblad; Elinore F McCance-Katz; Scott E Provost; Jeffrey Selzer; Eugene C Somoza; Susan C Sonne; Walter Ling
Journal:  Arch Gen Psychiatry       Date:  2011-11-07

3.  The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

Authors:  Lynn E Sullivan; Marek Chawarski; Patrick G O'Connor; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2005-07       Impact factor: 4.492

4.  Methods of detoxification and their role in treating patients with opioid dependence.

Authors:  Patrick G O'Connor
Journal:  JAMA       Date:  2005-08-24       Impact factor: 56.272

5.  Shortages of medical personnel at community health centers: implications for planned expansion.

Authors:  Roger A Rosenblatt; C Holly A Andrilla; Thomas Curtin; L Gary Hart
Journal:  JAMA       Date:  2006-03-01       Impact factor: 56.272

6.  Addiction is a brain disease, and it matters.

Authors:  A I Leshner
Journal:  Science       Date:  1997-10-03       Impact factor: 47.728

7.  Substance abuse by youth and young adults in rural America.

Authors:  David Lambert; John A Gale; David Hartley
Journal:  J Rural Health       Date:  2008       Impact factor: 4.333

8.  Association between opioid prescribing patterns and opioid overdose-related deaths.

Authors:  Amy S B Bohnert; Marcia Valenstein; Matthew J Bair; Dara Ganoczy; John F McCarthy; Mark A Ilgen; Frederic C Blow
Journal:  JAMA       Date:  2011-04-06       Impact factor: 56.272

9.  Societal costs of prescription opioid abuse, dependence, and misuse in the United States.

Authors:  Howard G Birnbaum; Alan G White; Matt Schiller; Tracy Waldman; Jody M Cleveland; Carl L Roland
Journal:  Pain Med       Date:  2011-03-10       Impact factor: 3.750

Review 10.  Effective medical treatment of opiate addiction. National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction.

Authors: 
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

View more
  8 in total

Review 1.  Implementing Treatment of Opioid-Use Disorder in Rural Settings: a Focus on HIV and Hepatitis C Prevention and Treatment.

Authors:  Jennifer R Havens; Sharon L Walsh; P Todd Korthuis; David A Fiellin
Journal:  Curr HIV/AIDS Rep       Date:  2018-08       Impact factor: 5.071

2.  Assessing Differences in the Availability of Opioid Addiction Therapy Options: Rural Versus Urban and American Indian Reservation Versus Nonreservation.

Authors:  Katherine A Hirchak; Sean M Murphy
Journal:  J Rural Health       Date:  2016-03-14       Impact factor: 4.333

3.  Comparing the feasibility of four web-based recruitment strategies to evaluate the treatment preferences of rural and urban adults who misuse non-prescribed opioids.

Authors:  Elizabeth C Saunders; Alan J Budney; Patricia Cavazos-Rehg; Emily Scherer; Lisa A Marsch
Journal:  Prev Med       Date:  2021-09-07       Impact factor: 4.018

4.  Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial.

Authors:  Sean M Murphy; Aimee N C Campbell; Udi E Ghitza; Tiffany L Kyle; Genie L Bailey; Edward V Nunes; Daniel Polsky
Journal:  Drug Alcohol Depend       Date:  2016-01-30       Impact factor: 4.492

Review 5.  Barriers and facilitators to opioid agonist therapy in rural and remote communities in Canada: an integrative review.

Authors:  Em M Pijl; Abeer Alraja; Elsie Duff; Carol Cooke; Stephen Dash; Nichole Nayak; Jesse Lamoureux; Ginette Poulin; Erin Knight; Ben Fry
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-08-26

Review 6.  Rural, Pregnant, and Opioid Dependent: A Systematic Review.

Authors:  Naana Afua Jumah
Journal:  Subst Abuse       Date:  2016-06-20

7.  Opioid prescribing and opioid-overdose deaths in Michigan: Urban-rural comparisons and changes across 2013-2017.

Authors:  Jamey J Lister; Jennifer D Ellis; Miyoung Yoon
Journal:  Addict Behav Rep       Date:  2019-11-15

8.  Comparison of Rural vs Urban Direct-to-Physician Commercial Promotion of Medications for Treating Opioid Use Disorder.

Authors:  Thuy Nguyen; Barbara Andraka-Christou; Kosali Simon; W David Bradford
Journal:  JAMA Netw Open       Date:  2019-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.